Chris Schaefer is Senior Vice President, Corporate Development, for PharMerica. In this role, Chris leads M&A transaction sourcing and execution across PharMerica’s long-term care pharmacy, home infusion, specialty pharmacy and hospital pharmacy management businesses and manages numerous strategic and organic development activities. Since he joined the company, PharMerica has completed approximately 40 M&A-related transactions.
Chris is a seasoned finance, operations and transaction professional with over 20 years of progressive experience focused on driving growth and financial performance across the continuum of healthcare products and services. He joined PharMerica in 2013 from CIT Healthcare, where he was a Director in Healthcare Investment Banking, providing leveraged loans and M&A advisory primarily to financial sponsor-backed healthcare companies. Prior to CIT, he worked in business development with Boston Heart Diagnostics, and spent approximately 10 years in investment banking, including roles at BT Alex. Brown, Robertson Stephens, UBS and Thomas Weisel Partners. Over the course of his career, Chris has completed approximately 100 transactions with aggregate value of over $10 billion.
Chris earned an A.B. in Economics from Harvard University and an MBA from New York University’s Stern School of Business.